An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)

NCT01168349 · clinicaltrials.gov ↗

COMPLETED

Status

1060

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia, Neoplasms

Interventions

DRUG: epoetin beta [NeoRecormon]

Sponsor

Hoffmann-La Roche